Basem Al-Shayeb

Basem Al-Shayeb, is the founder and former Chief Technology Officer of Amber Bio, which aims to develop multi-kilobase RNA editing therapies and has raised $26 million in funding. He is a researcher at the Innovative Genomics Institute. He led the discovery of the largest known bacteriophages,   the smallest CRISPR gene editing systems,    and Borgs in methane-oxidizing archaea. He was named Forbes 30 Under 30 and Arab America's 30 Under 30.